CDISC Announces Speakers from IMI, FDA and EMA for 10th Europe Interchange in Germany

Share Article

The Clinical Data Interchange Standards Consortium (CDISC) is proud to announce the 10th CDISC Europe Interchange, to be held 22-26 April 2013 near Frankfurt, Germany. The conference, planned by the CDISC European Coordinating Committee (E3C), will include an all-star list of speakers.

The Clinical Data Interchange Standards Consortium (CDISC) is proud to announce the 10th CDISC Europe Interchange, to be held 22-26 April 2013 near Frankfurt, Germany. The conference, planned by the CDISC European Coordinating Committee (E3C), will include an all-star list of speakers.

The 2013 Europe Interchange Keynote will be delivered by Dr. Michel Goldman, head of the Innovative Medicines Initiative (IMI). Frank Petavy of the European Medicines Agency (EMA) will give a presentation on the Clinical Trial Transparency Initiative, and Dr. Charles Cooper of the U.S. Food and Drug Administration (FDA) will present on Data Standards in the FDA – Challenges and Processes. Additional Interchange speakers will represent TransCelerate Biopharma and CDISC members and standards adopters. “We are extremely pleased that experts will be presenting on behalf of FDA, EMA and IMI during this 10th CDISC European Interchange, which will be held in Bad Nauheim (near Frankfurt), where Elvis Presley spent two years of his life,” said Peter van Reusel, who chairs the E3C. “We can look forward to a very special evening event, for which our European Interchanges have become renowned.”

CDISC Interchanges offer the rare opportunity for attendees to network and to gain information about best practices in clinical data standards implementation and the associated value. There will also be a pre-conference meeting of the CDISC Advisory Board, comprised of representatives from Platinum CDISC member organizations. In addition to the conference, CDISC will also offer official authorized CDISC educational courses during the week. Courses offered during the Interchange include SDTM, BRIDG, ADaM, CDASH, Controlled Terminology and ODM. The growing interest in CDISC in Europe, especially through the IMI and EMA Initiatives, has stimulated the need for such CDISC educational opportunities.

The CDISC Europe Interchange attendance is expected to be at an all-time high for 2013. Interested parties are encouraged to plan their attendance and look into sponsorship and exhibitor opportunities early. For more information, please visit http://www.cdisc.org/interchange.

ABOUT CDISC
CDISC is a 501(c)(3) global non-profit charitable organization, with over 300 supporting member organizations from across the clinical research and healthcare arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning healthcare system. The CDISC Vision is to inform patient care and safety through higher quality medical research.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Diana Harakeh
CDISC
512 689 9646
Email >
Visit website